{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T21:10:37Z","timestamp":1787605837924,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"am","delay-in-days":235,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["U01EY034686"],"award-info":[{"award-number":["U01EY034686"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R61EY032468"],"award-info":[{"award-number":["R61EY032468"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30EY014801"],"award-info":[{"award-number":["P30EY014801"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY026174"],"award-info":[{"award-number":["R01EY026174"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I21 RX003883"],"award-info":[{"award-number":["I21 RX003883"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 BX004893"],"award-info":[{"award-number":["I01 BX004893"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015728","name":"Clinical Science Research and Development","doi-asserted-by":"publisher","award":["I01 CX002015"],"award-info":[{"award-number":["I01 CX002015"]}],"id":[{"id":"10.13039\/100015728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0820"],"award-info":[{"award-number":["W81XWH-20-1-0820"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0579"],"award-info":[{"award-number":["W81XWH-20-1-0579"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jtos.2025.02.007","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T11:23:36Z","timestamp":1739359416000},"page":"24-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Impact of botulinum toxin type A on ocular pain with neuropathic features"],"prefix":"10.1016","volume":"37","author":[{"given":"Elyana V.T.","family":"Locatelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaxon J.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Betz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan J.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole B.","family":"Kantor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R.","family":"Felix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3026-6155","authenticated-orcid":false,"given":"Anat","family":"Galor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2025.02.007_bib1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2025.02.007_bib2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2025.02.007_bib3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jtos.2017.05.002","article-title":"TFOS DEWS II pain and sensation report","volume":"15","author":"Belmonte","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2025.02.007_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jtos.2017.10.001","article-title":"Neuropathic pain and dry eye","volume":"16","author":"Galor","year":"2018","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2025.02.007_bib5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/bjophthalmol-2015-307094","article-title":"Incomplete response to artificial tears is associated with features of neuropathic ocular pain","volume":"100","author":"Galor","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2025.02.007_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/bjophthalmol-2015-306842","article-title":"Blood-derived topical therapy for ocular surface diseases","volume":"100","author":"Soni","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2025.02.007_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.914809","article-title":"Editorial: eye pain: etiology and therapeutic approaches","volume":"13","author":"Rusciano","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jtos.2025.02.007_bib8","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ajo.2011.11.030","article-title":"Impact of ocular surface symptoms on quality of life in a United States veterans affairs population","volume":"153","author":"Pouyeh","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2025.02.007_bib9","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/j.pain.0000000000001552","article-title":"Modification of the neuropathic pain symptom inventory for use in eye pain (NPSI-eye)","volume":"160","author":"Farhangi","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.jtos.2025.02.007_bib10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/bjophthalmol-2018-313471","article-title":"Individuals with migraine have a different dry eye symptom profile than individuals without migraine","volume":"104","author":"Farhangi","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2025.02.007_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ajo.2015.11.017","article-title":"Clinical characteristics of dry eye patients with chronic pain syndromes","volume":"162","author":"Vehof","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2025.02.007_bib12","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1136\/bjophthalmol-2016-309658","article-title":"Evidence of central sensitisation in those with dry eye symptoms and neuropathic-like ocular pain complaints: incomplete response to topical anaesthesia and generalised heightened sensitivity to evoked pain","volume":"101","author":"Crane","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2025.02.007_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/tvst.12.3.7","article-title":"Topical ocular TRPV1 antagonist SAF312 (libvatrep) for postoperative pain after photorefractive keratectomy","volume":"12","author":"Thompson","year":"2023","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.jtos.2025.02.007_bib14","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.ophtha.2017.08.004","article-title":"Neuropathic corneal pain: approaches for management","volume":"124","author":"Dieckmann","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2025.02.007_bib15","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/ner.13402","article-title":"Long-term trigeminal nerve stimulation as a treatment for ocular pain","volume":"24","author":"Mehra","year":"2021","journal-title":"Neuromodulation"},{"key":"10.1016\/j.jtos.2025.02.007_bib16","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.2147\/JPR.S168650","article-title":"Botulinum toxin-A for the treatment of neuralgia: a systematic review and meta-analysis","volume":"11","author":"Meng","year":"2018","journal-title":"J Pain Res"},{"key":"10.1016\/j.jtos.2025.02.007_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/s-0036-1571953","article-title":"Botulinum toxin treatment of neuropathic pain","volume":"36","author":"Mittal","year":"2016","journal-title":"Semin Neurol"},{"key":"10.1016\/j.jtos.2025.02.007_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1159\/000509853","article-title":"Effectiveness, safety, and health-related quality of life of chronic migraine patients treated with onabotulinum toxin A","volume":"83","author":"Beckmann","year":"2020","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jtos.2025.02.007_bib19","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/bjophthalmol-2018-312649","article-title":"Photophobia and sensations of dryness in patients with migraine occur independent of baseline tear volume and improve following botulinum toxin A injections","volume":"103","author":"Diel","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2025.02.007_bib20","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/j.1526-4610.2010.01766.x","article-title":"Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program","volume":"50","author":"Blumenfeld","year":"2010","journal-title":"Headache"},{"key":"10.1016\/j.jtos.2025.02.007_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12040214","article-title":"A proposal for botulinum toxin type A injection into the temporal region in chronic migraine headache","volume":"12","author":"Kim","year":"2020","journal-title":"Toxins (Basel)."},{"key":"10.1016\/j.jtos.2025.02.007_bib22","article-title":"Periorbital botulinum toxin A improves photophobia and sensations of dryness in patients without migraine: case series of four patients","volume":"19","author":"Venkateswaran","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.jtos.2025.02.007_bib23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40135-017-0152-1","article-title":"Diagnosis and treatment of ocular pain: the ophthalmologist's perspective","volume":"5","author":"Jacobs","year":"2017","journal-title":"Curr Ophthalmol Rep."},{"key":"10.1016\/j.jtos.2025.02.007_bib24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/ICL.0000000000000249","article-title":"Characteristics of ocular pain complaints in patients with idiopathic dry eye symptoms","volume":"43","author":"Kalangara","year":"2017","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jtos.2025.02.007_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clae.2009.12.010","article-title":"Validation of the 5-Item Dry Eye Questionnaire (DEQ-5): discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses","volume":"33","author":"Chalmers","year":"2010","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.jtos.2025.02.007_bib26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the ocular surface disease Index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2025.02.007_bib27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0304-3959(85)90004-1","article-title":"The West haven-yale multidimensional pain inventory (WHYMPI)","volume":"23","author":"Kerns","year":"1985","journal-title":"Pain"},{"key":"10.1016\/j.jtos.2025.02.007_bib28","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.2147\/OPTH.S121256","article-title":"Presence or absence of ocular surface inflammation directs clinical and therapeutic management of dry eye","volume":"10","author":"Sambursky","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2025.02.007_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40123-020-00263-9","article-title":"Ocular surface pain: a narrative review","volume":"9","author":"Mehra","year":"2020","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.jtos.2025.02.007_bib30","series-title":"Acute pain","author":"Walker Bjp","year":"2019"},{"key":"10.1016\/j.jtos.2025.02.007_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1542-0124(12)70139-8","article-title":"Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading","volume":"1","author":"Foulks","year":"2003","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2025.02.007_bib32","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II diagnostic methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2025.02.007_bib33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1089\/jop.2023.0080","article-title":"Evaluation of the impact of meibomian gland dysfunction using a novel patient-reported outcome instrument","volume":"40","author":"Ajouz","year":"2024","journal-title":"J Ocul Pharmacol Therapeut"},{"key":"10.1016\/j.jtos.2025.02.007_bib34","article-title":"Long-term management of migraine with OnabotulinumtoxinA (botox) vs calcitonin gene-related peptide antibodies (Anti-CGRP)","volume":"15","author":"Pallapothu","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jtos.2025.02.007_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ophtha.2017.09.031","article-title":"Botulinum toxin A for the treatment of photophobia and dry eye","volume":"125","author":"Diel","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2025.02.007_bib36","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/bmj.316.7139.1236","article-title":"What's wrong with Bonferroni adjustments","volume":"316","author":"Perneger","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.jtos.2025.02.007_bib37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jtos.2023.09.009","article-title":"Evaluation of ocular neuropathic pain","volume":"30","author":"Le","year":"2023","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2025.02.007_bib38","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1526-4610.2007.00914.x","article-title":"Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache","volume":"48","author":"Mathew","year":"2008","journal-title":"Headache"},{"key":"10.1016\/j.jtos.2025.02.007_bib39","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.pmn.2015.01.006","article-title":"Effectiveness of three types of interventions in patients with fibromyalgia in a region of southern catalonia","volume":"16","author":"Montes\u00f3-Curto","year":"2015","journal-title":"Pain Manag Nurs"},{"key":"10.1016\/j.jtos.2025.02.007_bib40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/WNF.0b013e31829cb60e","article-title":"Acute treatment of trigeminal neuralgia with onabotulinum toxin A","volume":"36","author":"Z\u00fa\u00f1iga","year":"2013","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.jtos.2025.02.007_bib41","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1474-4422(16)00017-X","article-title":"Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial","volume":"15","author":"Attal","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jtos.2025.02.007_bib42","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.pain.2006.09.012","article-title":"Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A","volume":"125","author":"Jakubowski","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.jtos.2025.02.007_bib43","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/j.1526-4610.2008.01089.x","article-title":"Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study","volume":"48","author":"Taylor","year":"2008","journal-title":"Headache"},{"key":"10.1016\/j.jtos.2025.02.007_bib44","doi-asserted-by":"crossref","DOI":"10.1177\/20503121231218985","article-title":"Shedding light on neuropathic pain: current and emerging tools for diagnosis, screening, and quantification","volume":"12","author":"Hamdan","year":"2024","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.jtos.2025.02.007_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.neuro.051508.135531","article-title":"Neuropathic pain: a maladaptive response of the nervous system to damage","volume":"32","author":"Costigan","year":"2009","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.jtos.2025.02.007_bib46","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/14728222.2022.2122438","article-title":"Neuropathic ocular surface pain: emerging drug targets and therapeutic implications","volume":"26","author":"Patel","year":"2022","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jtos.2025.02.007_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101424","article-title":"Corneal nerve abnormalities in painful dry eye disease patients","volume":"9","author":"Guerrero-Moreno","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jtos.2025.02.007_bib48","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.semarthrit.2015.03.003","article-title":"Small fiber neuropathy in women with fibromyalgia. An in vivo assessment using corneal confocal bio-microscopy","volume":"45","author":"Ramirez","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jtos.2025.02.007_bib49","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/head.12547","article-title":"Chronic migraine is associated with reduced corneal nerve fiber density and symptoms of dry eye","volume":"55","author":"Kinard","year":"2015","journal-title":"Headache"},{"key":"10.1016\/j.jtos.2025.02.007_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11080459","article-title":"Mechanisms of botulinum toxin type A action on pain","volume":"11","author":"Matak","year":"2019","journal-title":"Toxins (Basel)."},{"key":"10.1016\/j.jtos.2025.02.007_bib51","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/j.pain.0000000000000119","article-title":"OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine","volume":"156","author":"Cernuda-Morollon","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.jtos.2025.02.007_bib52","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bpa.2020.06.007","article-title":"An evidence-based review of CGRP mechanisms in the propagation of chronic visceral pain","volume":"34","author":"Urits","year":"2020","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1016\/j.jtos.2025.02.007_bib53","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/bjophthalmol-2020-316417","article-title":"Photophobia: shared pathophysiology underlying dry eye disease, migraine and traumatic brain injury leading to central neuroplasticity of the trigeminothalamic pathway","volume":"105","author":"Diel","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2025.02.007_bib54","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/j.pain.0000000000003141","article-title":"An experimental model for primary neuropathic corneal pain induced by long ciliary nerve ligation in rats","volume":"165","author":"Wu","year":"2024","journal-title":"Pain"},{"key":"10.1016\/j.jtos.2025.02.007_bib55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbi.2013.01.088","article-title":"Botulinum toxin A increases analgesic effects of morphine, counters development of morphine tolerance and modulates glia activation and mu opioid receptor expression in neuropathic mice","volume":"32","author":"Vacca","year":"2013","journal-title":"Brain Behav Immun"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012425000308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012425000308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:28:53Z","timestamp":1778617733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012425000308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":55,"alternative-id":["S1542012425000308"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2025.02.007","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of botulinum toxin type A on ocular pain with neuropathic features","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2025.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}